( November 8, 2019, 9:46 AM EST) -- WASHINGTON, D.C. — Plaintiffs in six federal lawsuits on Nov. 4 filed a motion asking a judicial panel to centralize their Zantac cancer and refund claims into a multidistrict litigation in the U.S. District Court for the District of New Jersey (In Re: Zantac (Ranitidine) Products Liability Litigation, MDL Docket No. 2924, JPMDL)....